Mizmedi Hospital iDream Research Institute.

Mizmedi Hospital iDream Research Institute.

View original image


[Asia Economy Reporter Lee Gwanju] The iDream Research Institute at Seongsam Medical Foundation Mizmedi Hospital announced on the 2nd that it received an A grade in the ‘2021 Genetic Testing Institution Quality Evaluation’ conducted by the Korea Genetic Testing Evaluation Institute.


Mizmedi Hospital has received an A grade for 12 consecutive years since the genetic testing institution quality evaluation was implemented in 2010. In this evaluation, it received an A grade in all categories including laboratory operation such as facilities, equipment, and personnel, as well as evaluations of molecular genetics and cytogenetics. In particular, it scored 100 points in the external quality control section, being recognized as an excellent genetic testing institution.


The iDream Research Institute at Mizmedi Hospital has led infertility treatment based on pioneering and outstanding technologies and continuous research in the field of infertility, including the world’s first successful embryo transfer through the uterine wall in 1991, the world’s first successful normal pregnancy in habitual miscarriage patients using fluorescent direct hybridization in 1995, the first successful in vitro fertilization procedure using intracytoplasmic sperm injection in Korea in 1996, the first microsurgical testicular tissue extraction surgery using a surgical microscope in Korea in 2001, and the introduction of a test method for sperm nuclear DNA damage in Korea in 2006. In January last year, it achieved the remarkable success of a 47-year-old woman’s in vitro fertilization procedure followed by a safe delivery.



Lee Hyungsong, director of the iDream Research Institute at Mizmedi Hospital, said, “Receiving an A grade for 12 consecutive years in genetic testing institutions recognizes the objectivity and reliability of prenatal diagnosis and other genetic tests. We will continue to do our best to increase the pregnancy success rate of infertile couples through systematic management not only as a genetic testing institution but also as an embryo generation medical institution.”


This content was produced with the assistance of AI translation services.

© The Asia Business Daily(www.asiae.co.kr). All rights reserved.

Today’s Briefing